Exelixis Inc. buy Royal Bank of Canada
Start price
26.09.24
/
50%
€23.32
Target price
26.09.25
€24.17
Performance (%)
41.55%
End price
27.09.25
€33.01
Summary
This prediction ended on 27.09.25 with a price of €33.01. The BUY prediction by Royal_Bank_of_Canada for Exelixis Inc. saw massive gains of 41.55%. Royal_Bank_of_Canada has a follow-up prediction for Exelixis Inc. where he still thinks Exelixis Inc. is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Exelixis Inc. | 1.033% | 1.033% | 19.855% |
| iShares Core DAX® | 3.593% | 3.931% | 15.378% |
| iShares Nasdaq 100 | 5.810% | 5.518% | 41.455% |
| iShares Nikkei 225® | 4.075% | 8.460% | 48.947% |
| iShares S&P 500 | 4.142% | 4.039% | 31.594% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Exelixis Inc. diskutieren
Exelixis, Inc. (NASDAQ: EXEL) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $27.00 price target on the stock.
Ratings data for EXEL provided by MarketBeat
In the thread Trading Exelixis Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten